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GABAA receptors mediate most of the fast inhibitory transmission in the CNS. They form heteromeric complexes assembled from a large 
family of subunit genes. The existence of multiple GABAA receptor subtypes differing in subunit composition, localization and functional 
properties underlies their role for ﬁ  ne-tuning of neuronal circuits and genesis of network oscillations. The differential regulation of GABAA 
receptor subtypes represents a major facet of homeostatic synaptic plasticity and contributes to the excitation/inhibition (E/I) balance under 
physiological conditions and upon pathological challenges. The purpose of this review is to discuss recent ﬁ  ndings highlighting the signiﬁ  cance 
of GABAA receptor heterogeneity for the concept of E/I balance and its relevance for epilepsy. Speciﬁ  cally, we address the following issues: 
(1) role for tonic inhibition, mediated by extrasynaptic GABAA receptors, for controlling neuronal excitability; (2) signiﬁ  cance of chloride ion 
transport for maintenance of the E/I balance in adult brain; and (3) molecular mechanisms underlying GABAA receptor regulation (trafﬁ  cking, 
posttranslational modiﬁ  cation, gene transcription) that are important for homoeostatic plasticity. Finally, the relevance of these ﬁ  ndings is 
discussed in light of the involvement of GABAA receptors in epileptic disorders, based on recent experimental studies of temporal lobe epilepsy 
(TLE) and absence seizures and on the identiﬁ  cation of mutations in GABAA receptor subunit genes underlying familial forms of epilepsy.
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INTRODUCTION
The convulsant effects of GABA and glycine receptor antagonists, and 
conversely the clinically relevant antiepileptic action of classical benzo-
diazepines, such as diazepam, led to the concept that epileptic seizures 
reﬂ  ect an imbalance between excitatory and inhibitory transmission in 
the brain (Bradford, 1995; Gale, 1992; Olsen and Avoli, 1997). This view 
was further supported by the strong epileptogenic effects of glutamate 
receptor agonists, in particular kainic acid (Ben-Ari et al., 1980; Sperk, 
1994). Unlike acute drug effects, which occur in an intact system, epi-
leptogenesis and recurrent seizures in chronic epilepsy likely reﬂ   ect 
  pathological disturbances of neuronal circuits that may have multiple 
origins. Furthermore, the simple view that GABAergic transmission acts 
like a break preventing overexcitation of neuronal circuits has been 
  challenged by the highly sophisticated anatomical and functional organi-
zation of GABAergic interneurons in cerebral cortex (Blatow et al., 2005; 
Markram et al., 2004). Rather, GABAergic function is required for ﬁ  ne-
tuning of neuronal circuits and its inﬂ  uence on cell ﬁ  ring and network 
oscillations is constrained spatially and temporally (Mann and Paulsen, 
2007; Tukker et al., 2007). Furthermore, GABAergic transmission, while 
typically qualiﬁ   ed as being inhibitory, can also be depolarizing, even 
under physiological conditions, in the adult brain (Gulledge and Stuart, 
2003; Szabadics et al., 2006). Finally, in epileptic tissue neuronal network 
undergo extensive rewiring that considerably changes the function of 
interneurons and their control over pyramidal cells (Cossart et al., 2005; 
Ratte and Lacaille, 2006). Therefore, the classical dichotomy between 
inhibitory and excitatory GABAergic/glutamatergic transmission has to be 
revised and the role of GABAergic transmission in epilepsy is much more 
complex than suggested by simple pharmacological experiments.
The purpose of this review is to summarize recent advances on the 
concept of E/I balance and its relevance for epilepsy and to discuss the 
signiﬁ  cance of GABAA receptor heterogeneity for the pathophysiology of 
epileptic disorders.
EPILEPSY
Epilepsy is a generic term encompassing multiple syndromes, with 
  distinct symptoms, etiology, prognosis, and treatments. The role of GABAA 
receptors in the pathophysiology of epilepsy has been examined experi-
mentally in most detail in two major diseases, namely absence epilepsy 
and temporal lobe epilepsy (TLE). In addition, the functional consequences 
of mutations associated with familial forms of epilepsies are now being 
analyzed in recombinant expression system and in vivo using transgenic 
mouse models carrying these mutations (Noebels, 2003).
Absence seizures can be genetically determined (GAERS, WAG/Rij rats) 
(van Luijtelaar and Sitnikova, 2006) or pharmacologically-induced, for 
example by treatment with a cholesterol biosynthesis inhibitor, AY-9944 
(Snead, 1992). They are characterized by low frequency spike-and-wave 
discharges reﬂ  ecting impaired thalamo-cortical function. Typically, they 
are aggravated by benzodiazepine agonists. TLE is mimicked by induc-
tion of a prolonged status epilepticus (either upon repetitive electrical 
stimulation of sensitive regions of the temporal lobe or by injection of a 
convulsant, such as kainic acid or pilocarpine), which is followed in most 
cases by the occurrence of spontaneous recurrent seizures (reviewed in 
Coulter et al., 2002). Kindling, either electrical or chemical, is also used 
to model TLE, with the major difference that the animals do not present 
with recurrent seizures. In both TLE and absence epilepsy, alterations 
of GABAA receptor expression, pharmacology, and functional properties 
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have been studied in detail over many years. Recent results highlighting 
novel features will be discussed in more detail in the sections “Phasic/
tonic inhibition” and “GABAA receptor plasticity in epilepsy”. Importantly, 
changes observed in experimental models need to be compared to alter-
ations taking place in the brain of TLE patients. The availability of tissue 
resected at surgery from patients with intractable epilepsy represents an 
invaluable source for understanding the pathophysiology of the disorder 
(Loup et al., 2006; Magloczky and Freund, 2005).
GABAA RECEPTORS AND EXCITATORY/
INHIBITORY (E/I) BALANCE
The concept of E/I balance has gained much weight following the discov-
ery of homeostatic synaptic plasticity, through which the level of activity 
of neuronal networks is maintained within a narrow window by locally 
adapting the strength and weight of synaptic transmission in response 
to external stimuli (Marder and Goaillard, 2006; Rich and Wenner, 2007; 
Turrigiano, 2007). Major factors contributing to homeostatic synaptic 
plasticity include intrinsic membrane properties of pre- and postsynap-
tic neurons, patterns of synaptic inputs, non-synaptic interactions with 
neighboring cells, including glial cells, ionic composition of the extracel-
lular ﬂ  uid, and hormonal inﬂ  uences. Implicitly, an altered E/I balance, 
  frequently postulated as mechanism underlying epileptogenesis and 
  seizure generation, postulates a disturbance in homeostatic plasticity 
resulting from either insufﬁ  cient or excessive compensatory mechanisms 
in response to a change in network activity.
In this review, we focus on three main factors underlying the contribution 
of GABAA receptors for homeostatic synaptic plasticity (Mody, 2005). The 
ﬁ  rst of these factors is tonic inhibition, mediated primarily by extra- or peri-
synaptic receptors. Although tonic inhibition typically is evidenced in patch 
clamp recordings by a reduction in holding current (typically 10–100 pA) 
upon application of a GABAA receptor antagonist, it represents a signiﬁ  cant 
fraction of GABA-mediated charge transfer and is therefore likely to have a 
strong impact on neuronal excitability. The second factor is the regulation 
of Cl− ion ﬂ  uxes upon opening of GABAA receptors, which are determined 
by speciﬁ  c potassium-chloride co-transporters such as NKCC1 and KCC2. 
In addition of being developmentally regulated (Rivera et al., 2005), these 
co-transporters undergo rapid changes in expression and function under 
pathological conditions, leading to chronic dysregulation of GABAergic inhi-
bition (Price et al., 2005). The third factor is the activity-dependent regula-
tion of GABAergic and glutamatergic synapse function, recently brought to 
light by systematic analyses of the effects of chronic epileptiform activity or 
axon potential blockade in vitro (Costantin et al., 2005; Marty et al., 2004; 
Rutherford et al., 1997).
Phasic/tonic inhibition
Phasic and tonic neurotransmission are used to discriminate between the 
short, spatially restricted action of transmitters activating postsynaptic 
receptors, and the continuous activation of receptors localized peri- or 
extrasynaptically by transmitter spillover into the extracellular space. 
Given the prolonged duration of tonic transmission compared to the short 
openings of ion channels, most of the total charge transported by ligand-
gated ion channels occurs via tonic transmission, suggesting a major 
role in modulating neuronal activity (Farrant and Nusser, 2005; Mody and 
Pearce, 2004; Semyanov et al., 2004).
The subunit composition of GABAA receptors appears to be a major 
determinant of phasic and tonic GABAergic transmission. The γ2 subu-
nit, which is present in the vast majority of GABAA receptor subtypes, 
is required for postsynaptic clustering of GABAA receptors and gephyrin 
(Essrich et al., 1998; Luscher and Fritschy, 2001; Schweizer et al., 2003), 
a cytoskeletal protein selectively concentrated in GABAergic and glycin-
ergic synapses in the CNS (Sassoè-Pognetto and Fritschy, 2000; Triller 
et al., 1985). Multiple GABAA receptor subtypes are clustered at postsyn-
aptic types in deﬁ  ned neuronal populations (α1-, α2-, α3-, and, in part, 
α5-GABAA receptors). A major additional property of the γ2 subunit is 
to confer diazepam sensitivity to receptor complexes containing these 
α subunit variants. It is important to note, however, that GABAA recep-
tors containing the γ2 subunit are not only conﬁ  ned to postsynaptic sites. 
For instance, most α5-GABAA receptors are extrasynaptic (Crestani et al., 
2002), contribute to tonic inhibition modulated by diazepam (Caraiscos 
et al., 2004; Glykys and Mody, 2006; Prenosil et al., 2006) and regulate 
the excitability of pyramidal cells (Bonin et  al., 2007). Consequently, 
postsynaptic and extrasynaptic receptors formed with the γ2 subunit are 
diazepam-sensitive and contribute to the pharmacological proﬁ  le of clas-
sical benzodiazepine-site agonists.
Receptors containing the δ subunit, in contrast to the γ2 subunit, 
appear to be excluded from postsynaptic sites, as demonstrated by 
  immunoelectron microscopy (Nusser et al., 1998; Wei et al., 2003). The 
δ subunit is associated mainly with the α4 subunit, e.g., in thalamus 
and dentate gyrus (Peng et al., 2002; Sun et al., 2004), or the α6 subu-
nit in cerebellar granule cells (Jones et al., 1997). These receptors are 
diazepam-insensitive (Kapur and Macdonald, 1996; Makela et al., 1997) 
but are selectively modulated by GABA agonists such as gaboxadol and 
muscimol (Drasbek and Jensen, 2005; Storustovu and Ebert, 2006) 
as well as neurosteroids (Belelli and Herd, 2003; Belelli et al., 2005; 
Stell et  al., 2003), pointing to possible novel target for drug therapy 
(Krogsgaard-Larsen et al., 2004). Importantly, GABAA receptors contain-
ing the α4 and/or δ subunit exhibit unique functional properties that may 
contribute to epileptogenesis and recurrent seizures upon altered expres-
sion, as occurs in TLE (Lagrange et al., 2007). δ subunit-null mice exhibit 
enhanced sensitivity to pentylenetetrazol-induced seizures, but it is not 
established whether this reﬂ  ects a reduced tonic inhibition in thalamo-
cortical circuits or a reduced availability of binding sites for endogenous 
neurosteroids with anticonvulsant activity (Spigelman et al., 2002).
Ectopic expression of the α6 subunit under the control of the Thy-1.2 
promoter has been used to assess the functional and pharmacological 
signiﬁ  cance of enhanced tonic inhibition. These transgenic mice over-
express α1/α6/β/γ2-GABAA receptors and exhibit a ﬁ  ve-fold increase in 
tonic inhibition in CA1 pyramidal cells (Wisden et al., 2002). Behaviorally, 
these mice are essentially normal, but are more sensitive than wild-type 
to the convulsant effects of GABAA receptor antagonists (Sinkkonen et al., 
2004), suggesting an imbalance between phasic and tonic inhibition, with 
an overall decrease in GABAergic synaptic strength.
Chloride ion homeostasis
A major facet of GABAergic transmission is the intimate link between 
GABAA receptor function and ion homeostasis. Therefore, multiple ATP-
dependent transport processes determine GABAergic signaling (Farrant 
and Kaila, 2007). GABAA receptors are primarily permeable to Cl− and 
HCO3− anions. Cl− gradients are determined by two major pumps acting 
in opposite fashion, NKCC1 and KCC2, whereas bicarbonate is produced 
by carbonic anhydrases. The relative expression level of these molecules 
changes markedly during development, thereby rendering the reversal 
potential of Cl− more negative (Farrant and Kaila, 2007, Fiumelli and 
Woodin, 2007; Rivera et al., 2005). An opposite change in Cl− reversal 
potential affecting GABAA-mediated transmission has been suggested to 
occur in neurological disorders and following brain trauma (De Koninck, 
2007, Huberfeld et al., 2007; Payne et al., 2003; Toyoda et al., 2003), 
due to reduced expression or function of KCC2. It should be empha-
sized, however, that it remains largely unclear, whether GABAA-mediated 
depolarization after down-regulation of KCC2 has an excitatory effect on 
postsynaptic neurons, or whether shunting inhibition or deactivation of 
voltage-gated Na+ channels predominate after GABAA receptor activation, 
resulting functionally in inhibition.
In any case, KCC2 expression and function are regulated on a 
short-time basis by activity-dependent mechanisms (Rivera et al., 2004), 
determined in particular changes in phosphorylation (Lee et al., 2007; 
Wake et al., 2007) and by the short half-life of this transporter. These 
speciﬁ  c properties of KCC2 provide a major tool for local and rapid adjust-
ments of Cl− ion ﬂ  uxes, and therefore network activity, in adult brain.GABAA receptors and epilepsy
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Activity-dependent changes in synaptic structure and function
Pharmacological enhancement or blockade of neuronal activity in vitro 
represents a simpliﬁ   ed model of epileptiform activity or removal of 
afferents (as would happen after a lesion), respectively. The effects are 
  evident on the molecular, functional, and structural level. To mention a 
few examples, enhanced activity has marked effects on   postsynaptic 
receptor mobility, reﬂ   ecting diffusion within the plasma membrane. 
The effect is Ca++-dependent and likely mediated by interactions with 
the actin cytoskeleton (Hanus et al., 2006). The induction of epileptiform 
activity in vitro by application of GABAA receptor antagonists regulates 
synaptic function in hippocampal neurons by selectively favoring the loss 
of synapses on spines but not on dendritic shafts, resulting in increased 
GABAergic inhibition (Zha et al., 2005). In contrast, activity deprivation 
in hippocampal slices can induce epileptiform discharges (Trasande 
and Ramirez, 2007) and, during development, markedly affects the 
balance between glutamatergic and GABAergic synapses (Marty et al., 
2000). Although multiple mechanisms are involved in these changes, 
neurotrophins and extracellular matrix proteins, including integrins or 
cell-adhesion molecules, for example, play an important role in synaptic 
plasticity and remodeling induced by chronic changes in network activity 
(Gall and Lynch, 2004, Kuipers and Bramham, 2006).
GABAA RECEPTOR PLASTICITY
Several mechanisms contribute to the dynamic regulation of GABAA 
receptor function, which is essential for ﬁ  ne tuning of neuronal networks 
and the generation of rhythmic activities under physiological conditions:
1. Regulation of GABAA receptor trafﬁ   cking, synaptic clustering, and 
cell-surface mobility (Kittler and Moss, 2001; Kneussel and Loebrich, 
2007; Thomas et  al., 2005). In particular, GABAA receptor inter-
nalization mediated by clathrin-coated vesicle endocytosis (Herring 
et al., 2003, van Rijnsoever et al., 2005) has emerged as a major 
  mechanism of short- and long-term plasticity of GABAergic synapses. 
Unlike AMPA receptors (Man et  al., 2000), GABAA receptor inter-
nalization is not triggered by agonist exposure but is regulated by 
 phosphorylation (Kanematsu et al., 2006). In addition, several tyrosine 
kinase receptor ligands, such as TNF-α, insulin, or BDNF also modu-
late GABAA receptor cell surface expression by regulating its rate of 
internalization and/or membrane insertion (Brünig et al., 2001; Gilbert 
et al., 2006; Jovanovic et al., 2004; Wan et al., 1997). Next, synaptic 
clustering of GABAA receptors is largely inter-dependent on the scaf-
folding   protein gephyrin. Thus, down-regulation of gephyrin expres-
sion by gene targeting or silencing leads to rapid disappearance of 
postsynaptic GABAA receptor clustering and loss of IPSCs (Essrich 
et al., 1998; Yu et al., 2007). Finally, cell surface mobility, reﬂ  ecting 
membrane diffusion, represents a major mechanism for the dynamic, 
short-term regulation of GABAA receptors available for synaptic trans-
mission (Thomas et al., 2005).
2.  Regulation of receptor functions by chemical modiﬁ  cation, with phos-
phorylation being one of the major covalent modiﬁ  ers. Increasing 
evidence indicates that chemical modiﬁ  cation affects receptor traf-
ﬁ  cking and cell surface expression, as well as intrinsic functions of 
the ligand-gated ion channel (Kittler and Moss, 2003; Hinkle and 
Macdonald, 2003). GABAA receptor palmitoylation, selectively of the 
γ2 subunit, represents an additional mechanism for regulation of traf-
ﬁ  cking, cell-surface expression and postsynaptic clustering (Keller 
et al., 2004; Rathenberg et al., 2004).
3. Regulation of subunit expression, at the transcriptional and 
  translational level (Steiger and Russek, 2004); this mechanism 
determines the abundance and subunit composition of GABAA 
receptors in a given cell type or brain region and is of particular 
relevance for physiological alterations of network function, such 
as occurring upon hormonal ﬂ  uctuations during the ovarian cycle 
(Brussaard and Herbison, 2000; Maguire et al., 2005) and during 
puberty (Shen et al., 2007).
GABAA RECEPTOR ALTERATION 
IN EPILEPSY
Changes in subunit composition
Alterations in GABAA receptor subunit expression and composition in 
  epilepsy are well documented in human (Loup et al., 2000, 2006) and 
in animal models (Gilby et al., 2005; Li et al., 2006; Nishimura et al., 
2005; Peng et al., 2004; Roberts et al., 2005). The latter studies extend 
previous work by demonstrating a major contribution of extrasynaptic 
GABAA receptors to the changes in inhibitory function that might under-
lie epileptogenesis and occurrence of chronic recurrent seizures. For 
example, in the mouse pilocarpine model of TLE, a profound decrease in 
δ subunit immunoreactivity was observed, correlating with a redistribu-
tion of the γ2 subunit from synaptic to perisynaptic sites, where it assem-
bled with the α4 subunit, which is normally associated with the δ subunit 
(Zhang et al., 2007). A down-regulation of the α5 subunit also occurs 
in CA1 pyramidal cells of pilocarpine-treated rats (Houser and Esclapez, 
2003), resulting in a loss of diazepam-sensitive tonic inhibition seen upon 
blockade of GABA reuptake (Scimemi et al., 2005). Despite this change, 
tonic inhibition is enhanced in pyramidal cells, suggesting compensatory 
up-regulation of other extrasynaptic GABAA receptors, possibly containing 
the α4 subunit.
Quite recently, region-speciﬁ   c changes in GABAA receptor func-
tion and expression have been reported in models of absence epilepsy 
(Bessaih et al., 2006; Li et al., 2006; Liu et al., 2007). In the pharmaco-
logical model of absence seizures induced by neonatal treatment with the 
cholesterol biosynthesis inhibitor AY-9944, a reduced expression of the 
α1 and γ2 subunit has been reported (Li et al., 2006), with distinct sex 
differences and temporal proﬁ  les, correlating with the higher incidence 
of absence seizures in female rats (Li et al., 2006). Electrophysiologically, 
in the GAERS strain, GABAA receptor-mediated currents are altered selec-
tively in the thalamic reticular nucleus, but not in ventrobasal complex 
or somatosensory cortex, with mIPSCs exhibiting enhanced ampli-
tude and reduced decay kinetics (Bessaih et al., 2006). Such changes 
might be accounted for by expression of the β1 subunit (Huntsman and 
Huguenard, 2006). Finally, in WAG/Rij rats, a loss of GABAA receptor α3 
subunit-immunoreactivity has been shown to occur without alteration in 
mRNA expression in the reticular thalamic nucleus (Liu et al., 2007), sug-
gesting a local and highly speciﬁ  c deﬁ  cit in GABAA receptor function as a 
possible cause of absence seizures in these mutant rats.
Mutations affecting GABAA receptor assembly and trafﬁ  cking
Several mutations in GABAA receptor subunits have been associated with 
familial idiopathic epilepsies, including childhood absence epilepsy (CAE), 
generalized epilepsy with febrile seizures plus (GEFS+) and juvenile myo-
clonic epilepsy (JME) (Heron et al., 2007; Noebels, 2003). Missense and 
frame shift mutations in the GABAA receptor α1 subunit gene (GABRA1; 
5q34) are associated with JME (Cossette et al., 2002) and childhood 
absence epilepsy (CAE) (Maljevic et al., 2006). By contrast, missense, 
splice site mutations, or deletions in the γ2 subunit gene (GABRG2; 5q34) 
have been found in families with GEFS+ and CAE with febrile   seizures 
(Audenaert et al., 2006; Baulac et al., 2001; Harkin et al., 2002; Kananura 
et al., 2002; Wallace et al., 2001). In recombinant expression systems, 
these missense mutations typically affect single channel gating and/or 
cell surface availability of GABAA receptors. The precise mechanism 
underlying seizure generation remains in most cases ill-deﬁ   ned. The 
GABAA receptor γ2 subunit R43Q mutation has been reported to impair 
assembly and cell surface expression of GABAA receptors (Baulac et al., 
2001; Bowser et al., 2002). The mutation causes an increase in intra-
cortical excitability in patients compared to unaffected relatives (Fedi 
et al., 2007). Intriguingly, the effect of the mutation was shown to be 
temperature-dependent, with cell surface expression being reduced 
in vitro at temperatures higher than 37ºC (Kang et al., 2006). However, 
since most GEFS+ patients do not carry this mutation, such a mecha-
nism alone is not sufﬁ  cient for explaining the onset of seizures. In fact, Fritschy
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other studies have shown that the γ2(R43Q) mutation affects GABAA 
  receptor cell surface trafﬁ  cking and subunit composition independently 
of temperature (Frugier et al., 2007). The reduction of cell  surface expres-
sion mainly affects extrasynaptic receptors containing the α5 subunit, 
without altering phasic inhibition mediated by synaptic GABAA receptors 
(Eugène et al., 2007). In the same study, these effects were contrasted 
to the γ2(K289M) mutation, which accelerates decay kinetics of mini-
ature and evoked postsynaptic inhibitory currents, but does not affect 
GABAA receptor trafﬁ  cking and cell surface expression. Another muta-
tion, α1(A322D), is characterized by reduced subunit expression due to 
enhanced proteosomal degradation, probably due to protein misfolding 
(Gallagher et al., 2007). Finally, two susceptibility variants (E177A and 
A220H) have been found in the δ subunit gene (GABRD; present pri-
marily in extrasynaptic GABAA receptors, see section “Phasic/tonic 
inhibition”), affecting channel kinetics and cell surface expression in 
recombinant systems (Dibbens et al., 2004; Feng et al., 2006). However, 
no segregation of A220H with epilepsy could be found in a subsequent 
analysis of a large family (Lenzen et al., 2005), and the signiﬁ  cance of 
these mutations remains to be established.
CONCLUSIONS AND PERSPECTIVES
The heteregeneous molecular structure of GABAA receptors and their 
  differential expression, trafﬁ  cking, localization, and function underscore 
their complex regulation. They contribute in multiple ways to the mainte-
nance of E/I balance and the pathophysiology of epilepsy. Consequently, 
much work remains to be done to conceive therapeutic applications 
exploiting speciﬁ  c facets of GABAA receptor heterogeneity. So far, data 
sets obtained with different methods cannot be integrated into a sin-
gle coherent picture, and multidisciplinary approaches will be required 
to grasp the signiﬁ   cance of GABAA receptors in homeostatic synap-
tic   plasticity. The postulated “imbalance” between synaptic excitation 
and inhibition has been a motor for studying the functional properties 
of GABAergic and glutamatergic synapses in great detail. However, it is 
too simple a model for allowing conceptual advances about the patho-
physiology of complex brain diseases, such as epilepsy disorders. While 
the present review focused solely on GABAA receptors, it is evident that 
other mechanisms contributing to synaptic homeostasis will have to be 
included in a global concept as a prerequisite for understanding and pre-
venting epileptogenesis and ictogenesis. Yet, the central role played by 
GABAergic transmission in the regulation of neuronal networks justiﬁ  es 
the current interest given to GABAA receptors in studies of epilepsy.
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